Skip to main navigation
About
Overview
Leadership
Area of Focus
Congestion in Heart Failure
Outpatient Parenteral Antimicrobial Treatment (OPAT)
Products
FUROSCIX® (furosemide injection) 80mg/10mL for subcutaneous use
Research & Development
80mg/1ml Auto-Injector
scCeftriaxone
Clinical Development & Medical Affairs
Investor Relations
Investor Relations
Investor Overview
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Corporate Governance
Governance Highlights
Committee Composition
Financial Information
SEC Filings
News & Events
News Releases
Event Calendar
Presentations
Investor Resources
Investor Faq
Information Request
E-mail Alerts
IR Contacts
ESG
Media Resources
Careers
Contact Us
Legal
Privacy Policy
Terms of Use
scPharmaceuticals
Presentations
Presentations
More information is coming soon.
Tools
Print Page
RSS Feeds
E-mail Alerts
IR Contacts
About
Overview
Leadership
Area of Focus
Congestion in Heart Failure
Outpatient Parenteral Antimicrobial Treatment (OPAT)
Research and Development
FUROSCIX
®
(furosemide injection) for subcutaneous administration
scCeftriaxone
Clinical Development & Medical Affairs
Investor Relations
Investor Relations
Investor Overview
Stock Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
Corporate Governance
Governance Highlights
Committee Composition
Financial Information
SEC Filings
News & Events
News Releases
Event Calendar
Presentations
Investor Resources
Investor Faq
Information Request
E-mail Alerts
IR Contacts
ESG
Careers
Working at
scPharmaceuticals
Career Opportunities
Contact
Legal
Privacy Policy
Terms of Use
